WO2003059356A3 - Novel anti-infectives - Google Patents
Novel anti-infectives Download PDFInfo
- Publication number
- WO2003059356A3 WO2003059356A3 PCT/US2002/034591 US0234591W WO03059356A3 WO 2003059356 A3 WO2003059356 A3 WO 2003059356A3 US 0234591 W US0234591 W US 0234591W WO 03059356 A3 WO03059356 A3 WO 03059356A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- infectives
- novel anti
- disclosed
- making
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002365198A AU2002365198A1 (en) | 2001-10-30 | 2002-10-28 | Novel anti-infectives |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33854201P | 2001-10-30 | 2001-10-30 | |
US60/338,542 | 2001-10-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003059356A2 WO2003059356A2 (en) | 2003-07-24 |
WO2003059356A3 true WO2003059356A3 (en) | 2004-01-22 |
Family
ID=23325196
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/034591 WO2003059356A2 (en) | 2001-10-30 | 2002-10-28 | Novel anti-infectives |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002365198A1 (en) |
WO (1) | WO2003059356A2 (en) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4738172B2 (en) * | 2002-11-01 | 2011-08-03 | アボット・ラボラトリーズ | Antiinfectives |
US7902203B2 (en) | 2002-11-01 | 2011-03-08 | Abbott Laboratories, Inc. | Anti-infective agents |
EP2361913A1 (en) * | 2002-11-01 | 2011-08-31 | Abbott Laboratories | Anti-infective agents |
CN103304541A (en) | 2004-02-20 | 2013-09-18 | 贝林格尔.英格海姆国际有限公司 | Viral polymerase inhibitors |
SG137868A1 (en) * | 2004-08-23 | 2007-12-28 | Hoffmann La Roche | Heterocyclic antiviral compounds |
AP2007004040A0 (en) | 2004-12-17 | 2007-06-30 | Anadys Pharmaceuticals Inc | Pyridazinone compounds |
ATE409179T1 (en) | 2004-12-21 | 2008-10-15 | Hoffmann La Roche | TETRALIN AND INDANDE DERIVATIVES AND THEIR APPLICATIONS AS 5-HT ANTAGONISTS |
BRPI0611388A2 (en) | 2005-05-04 | 2010-09-08 | Hoffmann La Roche | heterocyclic antiviral compounds, their use and pharmaceutical composition |
AU2007263084A1 (en) | 2006-06-20 | 2007-12-27 | F. Hoffmann-La Roche Ag | Tetralin and indane derivatives and uses thereof |
EP2041079A1 (en) | 2006-06-20 | 2009-04-01 | F. Hoffmann-Roche AG | Arylsulfonyl naphthalene derivatives and uses thereof |
WO2007147762A1 (en) | 2006-06-20 | 2007-12-27 | F. Hoffmann-La Roche Ag | Arylsulfonamidyl tetralin derivatives and uses thereof |
WO2007150001A1 (en) * | 2006-06-22 | 2007-12-27 | Anadys Pharmaceuticals, Inc. | Pyrro[1,2-b]pyridazinone compounds |
WO2008011337A1 (en) | 2006-07-19 | 2008-01-24 | Abbott Laboratories | Hcv inhibitors |
KR20090078347A (en) | 2006-10-10 | 2009-07-17 | 메디비르 아베 | Hcv nucleoside inhibitor |
WO2008073987A1 (en) * | 2006-12-12 | 2008-06-19 | Anadys Pharmaceuticals, Inc. | Saturated fused [1,2-b] pyridazinone compounds |
TW200840572A (en) | 2006-12-12 | 2008-10-16 | Anadys Pharmaceuticals Inc | 5,6-dihydro-1H-pyridin-2-one compounds |
UA100120C2 (en) | 2007-04-03 | 2012-11-26 | Анадис Фармасьютикалз, Инк. | 5,6-dihydro-1h-pyridin-2-one compounds |
US7834009B2 (en) | 2007-08-27 | 2010-11-16 | Anadys Pharmaceuticals, Inc. | 4-hydroxy-5,6-dihydro-1H-pyridin-2-one compounds |
GB0800855D0 (en) * | 2008-01-17 | 2008-02-27 | Syngenta Ltd | Herbicidal compounds |
WO2009152166A1 (en) | 2008-06-10 | 2009-12-17 | Anadys Pharmaceuticals, Inc. | [1,2,4]thiadiazine 1,1-dioxide compounds |
TW201026675A (en) | 2008-10-09 | 2010-07-16 | Anadys Pharmaceuticals Inc | 5,6-dihydro-1H-pyridin-2-one compounds |
ES2435799T3 (en) | 2008-10-09 | 2013-12-23 | Anadys Pharmaceuticals, Inc. | A method of inhibiting hepatitis C virus by combining a 5,6-dihydro-1H-pyridin-2-one and one or more additional antiviral compounds |
CN102203091B (en) * | 2008-10-29 | 2014-08-13 | 巴斯夫欧洲公司 | Substituted pyridines having a herbicidal effect |
WO2010100178A1 (en) | 2009-03-06 | 2010-09-10 | F. Hoffmann-La Roche Ag | Heterocyclic antiviral compounds |
AU2010240888A1 (en) | 2009-04-25 | 2011-11-17 | F. Hoffmann-La Roche Ag | Heterocyclic antiviral compounds |
JP2012527420A (en) * | 2009-05-20 | 2012-11-08 | エフ.ホフマン−ラ ロシュ アーゲー | Antiviral heterocyclic compounds |
SG176976A1 (en) | 2009-06-24 | 2012-02-28 | Hoffmann La Roche | Heterocyclic antiviral compound |
WO2011033045A1 (en) | 2009-09-21 | 2011-03-24 | F. Hoffmann-La Roche Ag | Heterocyclic antiviral compounds |
EP2493476A4 (en) | 2009-10-28 | 2013-06-19 | Anadys Pharmaceuticals Inc | Deuterated 5,6-dihydro-1h-pyridin-2-one compounds |
BR112012012085A2 (en) | 2009-11-21 | 2016-05-17 | Hoffmann La Roche | heterocyclic antiviral compounds |
US20120321590A1 (en) | 2011-04-06 | 2012-12-20 | Anadys Pharmaceuticals, Inc. | Bridged polycyclic compounds |
WO2021030278A1 (en) * | 2019-08-12 | 2021-02-18 | Aligos Therapeutics, Inc. | Bicyclic compounds |
-
2002
- 2002-10-28 WO PCT/US2002/034591 patent/WO2003059356A2/en not_active Application Discontinuation
- 2002-10-28 AU AU2002365198A patent/AU2002365198A1/en not_active Abandoned
Non-Patent Citations (2)
Title |
---|
CHEMISTRY OF HETEROCYCLIC COMPOUNDS (NEW YORK), vol. 36, no. 3, 2000, pages 346 - 350 * |
DATABASE CAPLUS [online] UKRAINETS ET AL.: "4-Hydroxy-2-quinolones. Part 42. Synthesis and biological activity of 1-substituted 2-oxo-3-(2H-1,2,4-benzothiadiazine-1,1-dioxid-3-yl)-4-Hydroxyquinolines", XP002956156, accession no. STN Database accession no. 2000:335217 * |
Also Published As
Publication number | Publication date |
---|---|
AU2002365198A1 (en) | 2003-07-30 |
WO2003059356A2 (en) | 2003-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003059356A3 (en) | Novel anti-infectives | |
MXPA03011329A (en) | Novel anti-infectives. | |
WO2003035617A3 (en) | Derivatives of uk-2a | |
MXPA03005960A (en) | Novel mixtures of microbial enzymes. | |
AU2002364528A1 (en) | Bio-implant and method of making the same | |
AU2002315389A1 (en) | Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof | |
WO2003045840A3 (en) | Mesoporous materials and methods | |
WO2003037262A3 (en) | Novel anit-infectives | |
AU2002315388A1 (en) | Novel phenylamino-pyrimidines and uses thereof | |
WO2004052313A3 (en) | Anti-infectives | |
WO2004058150A3 (en) | Anti-infectives | |
WO2004052312A3 (en) | Anti-infectives | |
AU2002237265A1 (en) | Ring-shaped seal | |
AU2002347778A1 (en) | Enzymes | |
WO2002034204A8 (en) | Calcilytic compounds | |
WO2004047751A3 (en) | Calcilytic compounds | |
WO2002098924A3 (en) | Compositions including fluorinated peroxides, methods of making, and the use thereof | |
AU2002337150A1 (en) | Microchamber | |
AUPR573601A0 (en) | Novel process | |
AU2002257273A1 (en) | Enzymes | |
AU2002308926A1 (en) | The method of preparing of n-n-alkyl benzoyl-2-sulfonylendoimine | |
AU2002348941A1 (en) | Calpain activators | |
AUPR482001A0 (en) | Metal-handling enzymes | |
AU2002315767A1 (en) | Novel aliphatic compounds, synthesis method and method of using the same | |
ZA200304986B (en) | Novel mixtures of microbial enzymes. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |